Sample Collection in Smoking Asthma

Completed

• Conditions: Asthma

• Registration Number: NCT01676467
• Lead Sponsor: Respivert Ltd

Brief Summary

This study will collect blood and sputum (phlegm) samples from subjects with asthma, smokers and normal healthy subjects, to compare the biological markers of disease and inflammation.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-08-21
• Study First Submitted QC: 2012-08-28
• Study First Posted: 2012-08-31
• Study Start: 2012-09
• Primary Completion: 2012-12
• Study Completion: 2012-12
• Status Verified: 2013-01
• Last Update Submitted: 2013-01-07
• Last Update Posted: 2013-01-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sputum and serum biomarkers	Day 10	Measurement of biomarkers of inflammation, including but not limited to: TNFα, IL-8, IFNγ, IP10 and eotaxin in sputum supernatant and serum will be collected and measured only once, at Visit 2 (Day 10).
Sputum cell count	Day 10	Sputum cell count (total cells, differentials and absolute number) at Visit 2 (Day 10).